Jan Lang is a partner in the Brussels and Berlin offices. He advises clients on all aspects of European and German antitrust law.

His practice focuses on merger control proceedings, cartel investigations, and abuse of dominance cases. Jan represents clients before the European Commission and the German Federal Cartel Office as well as in related proceedings before European and German courts. His extensive experience ranges from compliance matters and regulatory proceedings to subsequent antitrust administrative court proceedings and actions for damages.

Jan advises companies in various industries with a particular focus on technology, life sciences, and aviation companies. Prior to joining Morrison Foerster, Jan practiced in the Brussels office of another leading U.S. law firm, where he played a key role in building the firm’s office and European antitrust practice, handling complex, landmark transactional, investigative, and litigation matters. For his landmark success in a court case before the European Court of Justice, British trade journal The Lawyer awarded Jan and his team the title “European Competition or Antitrust Team of the Year 2023.”

Jan studied at the University of Bayreuth and completed his legal clerkship at the Berlin Court of Appeal. During his legal clerkship, he worked as a national expert for Germany on a report for the European Commission on the evaluation of Regulation 1/2003 with a particular focus on the right of access to file and the complaints system. He is also a co-author of a study for the ECON-Committee of the European Parliament: A Practitioner’s View on the Role and Powers of National Competition Authorities. Jan is a member of the Studienvereinigung Kartellrecht and the American Bar Association.

Jan is admitted to practice in Berlin and Brussels and speaks German and English.

Representative Experience

• A European airline in various disputes regarding abuse of a dominant market position, including litigation
• Condor in its successful challenge to the European Commission’s approval of COVID-19 aid to Lufthansa
• U.S. technology companies in an ongoing antitrust investigation by the European Commission
• Numerous national and international companies in global antitrust investigations, particularly in the automotive sector
• A leading U.S. company in obtaining full immunity in the European Commission’s “Car Battery Recycling” investigation
• A leading industrial company in obtaining full immunity in a purchasing cartel
• Horizon in its sale to Amgen for USD 28 billion
• Arena Pharmaceuticals in its sale to Pfizer for USD 6.7 billion
• Tableau in its sale to Salesforce for USD 15.7 billion
• Cornerstone in its sale to Clearlake for USD 5.2 billion